He had a background of long standing inactive Crohn's disease on ustekinumab (an interleukin[IL]-12 and IL-23 inhibitor), and more recently, stage IV melanoma (BRAF wild-type) with known symptomatic vertebral metastases. Here, BRAF is linked to melanoma.